Taking your patients through the doors of perception: How Australia’s psychedelic therapy clinics will work
Dr Paul Liknaitzky discusses the 'challenging, courageous' therapies his new clinics will soon offer.
The TGA’s decision to approve psychedelics for clinical use for treatment-resistant depression and PTSD has been condemned as risky and experimental by many leading psychiatrists.
It has been done nowhere else in the world outside of a clinical trial.
But community-based clinics are already coming, with fees expected in the region of $20,000.
There has been little detail on what the treatment actually involves which we hope this article will address.
